Wegovy Weight-Loss Pill Offers Injectables Alternative
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
Illegal weight loss injections: The rising black market crisis
Illegal weight loss injections are flooding the local market as high costs and obesity rates drive a dangerous market for GLP-1 agonists.
Aspen Boosted by Mounjaro: A New Era in Weight Loss
Aspen shares soar following the approval of Mounjaro for weight loss in South Africa. Discover the impact on obesity management.
Cheaper Weight-Loss Drugs for Global Health Needs
… Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
GLP-1 Drugs Lower Cancer Rates in Weight Loss Study
Find out how GLP-1 drugs like Ozempic and Wegovy can lower cancer risk while aiding in weight loss and diabetes control.
Novo Nordisk Hiring Freeze After Wegovy Sales Decline
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.
Ozempic and Mounjaro are reshaping South Africa’s health market
Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.
Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
GLP-1 drugs increase healthcare costs for obese patients
Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.